CTLA4 and colitis: Writing recently in Science, Lo and coworkers characterized a critical role of the gut microbiota in CTLA‐4 blockade‐induced colitis, revealing that an Fc domain‐deficient anti‐CTLA‐4 antibody can elicit antitumor responses effectively while avoiding the induction of colitis‐like disease.1